Scarica l'app Stockscreener
9.09
3.18%
0.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TPST Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.81
Aprire:
$8.75
Volume 24 ore:
121.89K
Relative Volume:
1.00
Capitalizzazione di mercato:
$33.51M
Reddito:
-
Utile/perdita netta:
$-31.11M
Rapporto P/E:
-5.9412
EPS:
-1.53
Flusso di cassa netto:
$-28.18M
1 W Prestazione:
+28.57%
1M Prestazione:
+30.79%
6M Prestazione:
-24.99%
1 anno Prestazione:
-36.43%
Intervallo 1D:
$8.66
$9.4753
Intervallo di 1 settimana:
$6.955
$9.4753
Portata 52W:
$5.3495
$28.34
Tempest Therapeutics Inc Stock (TPST) Company Profile
Nome
Tempest Therapeutics Inc
Settore
Industria
Telefono
415-798-8589
Indirizzo
2000 SIERRA POINT PARKWAY, BRISBANE
Confronta TPST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
9.0999 | 29.50M | 0 | -31.11M | -28.18M | -1.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.85 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.26 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.50 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.45 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
302.50 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-08 | Iniziato | Jefferies | Buy |
Tempest Therapeutics Inc Borsa (TPST) Ultime notizie
Quantitative breakdown of Tempest Therapeutics Inc. recent moveEarnings Recap Report & Expert Approved Momentum Trade Ideas - Newser
Pattern recognition hints at Tempest Therapeutics Inc. upsideJuly 2025 Short Interest & Growth Focused Investment Plans - Newser
What data driven models say about Tempest Therapeutics Inc.’s futureJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockJuly 2025 Momentum & AI Powered Market Trend Analysis - Newser
Analyzing drawdowns of Tempest Therapeutics Inc. with statistical toolsChart Signal and Short-Term Forecast Tracker - Newser
Can machine learning forecast Tempest Therapeutics Inc. recoveryWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Predicting Tempest Therapeutics Inc. trend using moving averagesFree Entry Alert With Low Drawdown Strategy - Newser
Is Tempest Therapeutics Inc. stock bottoming outBuy Zone Strategy with Pattern Recognition - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionFree High Return Stock Focus With Safety - Newser
Is Tempest Therapeutics Inc. a play on infrastructure spendingBottom Formation Alert - thegnnews.com
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceBuy Opportunity Forecast for Fast Traders - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.Free Risk Managed Intraday Trade Alerts - Newser
Tempest Therapeutics Reports Q2 2025 Financial Results - TipRanks
Tempest Therapeutics Inc. stock chart pattern explainedShort Squeeze Opportunities with Indicators - Newser
What makes Tempest Therapeutics Inc. stock price move sharplyYield Curve Outlook and Long-Term Implication Summary - Newser
Tempest Therapeutics TPST 2025Q2 Earnings Preview Downside Risk Amid Uncertain Revenue Expectations - AInvest
Tempest Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tempest Therapeutics reports Q2 EPS ($2.07), consensus ($2.65) - TipRanks
Tempest Therapeutics: A Case Study in Operational Turnaround and Biotech Resilience - AInvest
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Is it too late to sell Tempest Therapeutics Inc.Pattern Recognition Tool for ROI Investors - Newser
Tempest Therapeutics Inc. stock outlook for YEARFree Smart Trade Plans With Risk Protection - Newser
Real time alert setup for Tempest Therapeutics Inc. performanceInvestment Life Cycle Planning Summary - Newser
What technical models suggest about Tempest Therapeutics Inc.’s comeback - Newser
Multi factor analysis applied to Tempest Therapeutics Inc.Short Term Gain Strategy with AI Logic - Newser
Tempest Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayROI Focused Setup Screener With Exit Markers - Newser
Published on: 2025-08-09 23:28:19 - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityFree Chart Breakout Buy Signal Detection - Newser
Tempest Therapeutics Inc expected to post a loss of $2.60 a shareEarnings Preview - TradingView
Tempest Therapeutics (TPST) Expected to Announce Quarterly Earnings on Thursday - Defense World
Long term hold vs stop loss in Tempest Therapeutics Inc.Smart Forecast Signals from AI Models - Newser
Tempest Therapeutics Inc Azioni (TPST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):